Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-05-16
2000-03-07
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
424 9371, 4242771, 4242651, 4241841, 435 691, 530350, 530300, 530402, 536 2372, 514 8, A61K 39385, A61K 4505
Patent
active
060336692
ABSTRACT:
The present invention relates a novel class of biologically active compounds, to processes for their production and to their use in therapy. More particularly the invention provides immunogenic conjugates useful for generating T cell immunity against tumor-associated carbohydrate structures or against carbohydrate structures expressed on infectious agents and/or infected host cells. The said immunogenic conjugate comprises,(i) a peptide component capable of binding a MHC class I molecule; and (ii) a carbohydrate component having the immunogenic specificity of said carbohydrate structure.
REFERENCES:
patent: 5334379 (1994-08-01), Pillai et al.
patent: 5389530 (1995-02-01), Hakomori
patent: 5500215 (1996-03-01), Hakomori
Cui, et al., Science 278: 1623-1626 (1997).
Kawano, et al., Science 278: 1626-1629 (1997).
Carbone, et al., Glycobiology 7: 725-730 (1997).
Abdel-Motal et al, Immunology Letters, vol. 54, pp. 31-35, 1996.
Hakomori, Current Opinion in Immunology, 3:646-653 (1991).
Wang, et al., Tetrahedron Letters, vol. 32, No. 47, pp. 6827-6830 (1991).
Otvos et al., Tetrahedron Letters 31: 5889-5892 (1990).
Elofsson et al., Tetrahedron Letters 32: 7613-7616 (1991).
Uchiyama et al., Chem. Pharm. Bull. 39: 3091-3093 (1991).
Elliott et al., Nature 348: 195-197 (1990).
Ortmann et al., J. Immunol. 148: 1445-1450 (1992).
Rotzschke and Falk, Immunology Today 12: 447-455 (1991).
Tsomides and Eisen, J. Biol. Chem. 266: 3357-3360 (1991).
Jardetzky et al., Nature 353: 326-329 (1991).
Bouillot et al., Nature 339: 473-475 (1989).
Ishioka et al., (Abstract from Database) J. Immunol. 148: 2446-51 (1992).
Matsumura et al., Science 257: 927-934 (1992).
Macfarlan et al., Mol. Immunol. 23: 733-741 (1986).
Bowie et al., Science 247: 1306-1310 (1990).
Pleskova et al., Neoplasma 35: 657-664 (1988).
Houghten et al., Vaccines 86:21-25 (1986).
Misra et al., Immunogenetics 26: 204-210 (1987).
Pimlott et al., J. Immunol. 136: 6-11 (1986).
Henningsson et al., Cancer Immunol. Immunother. 25: 231-241 (1987).
O'Neill, Immunol. Cell Biol. 69: 159-165 (1991).
Hertel-Wulff et al., J. Exp. Med. 157: 987-997 (1983).
Bjorkman et al., Ann. Rev. Biochem. 59: 253-288 (1990).
Kumar et al., Proc. Natl. Acad. Sci. 87: 1337-1341 (1990).
Astra Aktiebolag
Mosher Mary E.
Salimi Ali R.
LandOfFree
Methods for generating cytotoxic T cells and treatment of diseas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for generating cytotoxic T cells and treatment of diseas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for generating cytotoxic T cells and treatment of diseas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-360264